Herophilus

📍 San Francisco, United States🗓 Founded 2017👥 16 employees💰 Last funded Aug 2018
Biotechnology Research🌐 herophilus.com
Website LinkedIn
Herophilus is a San Francisco based neurotherapeutics development company that employs AI-driven phenotypic screening to discover and develop novel drugs for complex brain diseases, disorders for which traditional discovery techniques have proved least successful. Herophilus industrializes the recent revolution in complex in vitro experimental science, leveraging robotic automation and machine learning, to characterize the etiology and expression of disease at molecular, cellular, and tissue levels. These "deep phenotypes"​ are exploited to identify novel therapeutic targets and drug treatments.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Hong Kong SAR
1
Investor activity2017–2018 · investors recorded per year
2017120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Herophilus?
Herophilus has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Herophilus last raise funding?
The most recent investment in Herophilus recorded on gritt.io was in August 2018.
When was Herophilus founded?
Herophilus was founded in 2017.
What industry is Herophilus in?
Herophilus operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Herophilus based?
Herophilus is headquartered in San Francisco, United States.